Daly AK - Search Results

1

CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease.

Atkinson A, Singleton AB, Steward A, Ince PG, Perry RH, McKeith IG, Fairbairn AF, Edwardson JA, Daly AK, Morris CM. Atkinson A, et al. Among authors: daly ak. Pharmacogenetics. 1999 Feb;9(1):31-5. doi: 10.1097/00008571-199902000-00005. Pharmacogenetics. 1999. PMID: 10208640

2

CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians in Los Angeles.

Leathart JB, London SJ, Steward A, Adams JD, Idle JR, Daly AK. Leathart JB, et al. Among authors: daly ak. Pharmacogenetics. 1998 Dec;8(6):529-41. doi: 10.1097/00008571-199812000-00010. Pharmacogenetics. 1998. PMID: 9918137

3

Nomenclature for human CYP2D6 alleles.

Daly AK, Brockmöller J, Broly F, Eichelbaum M, Evans WE, Gonzalez FJ, Huang JD, Idle JR, Ingelman-Sundberg M, Ishizaki T, Jacqz-Aigrain E, Meyer UA, Nebert DW, Steen VM, Wolf CR, Zanger UM. Daly AK, et al. Pharmacogenetics. 1996 Jun;6(3):193-201. doi: 10.1097/00008571-199606000-00001. Pharmacogenetics. 1996. PMID: 8807658

4

The cytochrome P450 CYP2D6 allelic variant CYP2D6J and related polymorphisms in a European population.

Armstrong M, Fairbrother K, Idle JR, Daly AK. Armstrong M, et al. Among authors: daly ak. Pharmacogenetics. 1994 Apr;4(2):73-81. doi: 10.1097/00008571-199404000-00004. Pharmacogenetics. 1994. PMID: 8081414

5

Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotype.

Daly AK, Fairbrother KS, Andreassen OA, London SJ, Idle JR, Steen VM. Daly AK, et al. Pharmacogenetics. 1996 Aug;6(4):319-28. doi: 10.1097/00008571-199608000-00005. Pharmacogenetics. 1996. PMID: 8873218

6

Analysis of cytochrome P450 polymorphisms.

Daly AK, Monkman SC, Smart J, Steward A, Cholerton S. Daly AK, et al. Methods Mol Biol. 1998;107:405-22. doi: 10.1385/0-89603-519-0:405. Methods Mol Biol. 1998. PMID: 14577249 No abstract available.

7

Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypes.

Daly AK, Armstrong M, Monkman SC, Idle ME, Idle JR. Daly AK, et al. Pharmacogenetics. 1991 Oct;1(1):33-41. doi: 10.1097/00008571-199110000-00006. Pharmacogenetics. 1991. PMID: 1688241

8

Detection and characterization of novel polymorphisms in the CYP2E1 gene.

Fairbrother KS, Grove J, de Waziers I, Steimel DT, Day CP, Crespi CL, Daly AK. Fairbrother KS, et al. Among authors: daly ak. Pharmacogenetics. 1998 Dec;8(6):543-52. doi: 10.1097/00008571-199812000-00011. Pharmacogenetics. 1998. PMID: 9918138

9

Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced hepatitis.

Aithal GP, Day CP, Leathart JB, Daly AK. Aithal GP, et al. Among authors: daly ak. Pharmacogenetics. 2000 Aug;10(6):511-8. doi: 10.1097/00008571-200008000-00004. Pharmacogenetics. 2000. PMID: 10975605

10

The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype.

Grove J, Brown AS, Daly AK, Bassendine MF, James OF, Day CP. Grove J, et al. Among authors: daly ak. Pharmacogenetics. 1998 Aug;8(4):335-42. doi: 10.1097/00008571-199808000-00007. Pharmacogenetics. 1998. PMID: 9731720

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters